Expression of p21Waf1/Cip1 predicts response and survival of esophageal cancer patients treated by chemoradiotherapy
- 1 December 2004
- journal article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 17 (4) , 315-321
- https://doi.org/10.1111/j.1442-2050.2004.00433.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancerBritish Journal of Surgery, 2001
- p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancerSurgery, 2000
- Expression of apoptosis-related proteins (p53, p21 WAF1 , bcl-2, and bax) and sensitivity to chemotherapy in squamous cell carcinoma of the esophagusInternational Journal of Clinical Oncology, 2000
- Antisense Blockade of p21/WAF1 Decreases Radiation-Induced G2 Arrest in Esophageal Squamous Cell CarcinomaJournal of Surgical Research, 1999
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- The role of p53, p21WAF1/C1P1, and bcl-2 in radioresistant colorectal carcinomaHuman Pathology, 1997
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- Downstaging of Esophageal Cancer After Preoperative Radiation and ChemotherapyAnnals of Surgery, 1995
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993